Managing the Contaminated Patient

Introduction

A radioactively contaminated patient who arrives at a hospital is, first and always, a patient — the radioactivity is a manageable complication, not the emergency. The single most important principle in radiation emergency medicine is that life-threatening medical conditions are treated first, because the acute medical threat almost always outweighs the radiological one. ¹⁷

This is counterintuitive, which is exactly why it has to be planned and rehearsed. Faced with a survey meter that is alarming, staff instinct can be to keep the patient at arm's length. But the dose to caregivers from a contaminated patient is typically low, and, as radiation-emergency clinicians put it plainly, no one dies from internal contamination itself. ² The failure mode in a real event is not staff overexposure — it is a stabilizable patient who does not get stabilized because the team froze over the radiation.

The medical physicist and radiation safety officer (RSO) are the people who make the calm, correct response possible: preplanning the emergency department, setting up contamination control that does not impede care, estimating internal intake, selecting FDA-approved decorporation agents, and keeping staff dose low and documented. This guide walks through that framework, grounded in NCRP and IAEA guidance. DRPS supports hospitals in building and auditing these plans through its radiation safety officer, radiation safety training, and medical physics consulting services across Florida, Maryland, Virginia, Washington DC, California, Nevada, Pennsylvania, New York, New Jersey, and Delaware.

Topic Explanation

Three words that are not the same: exposure, contamination, internal contamination

Clear terminology drives the whole response:

• Exposure (irradiation). The person was in a radiation field — like undergoing a radiograph — but is not radioactive afterward. An exposed-only patient needs no decontamination and poses no hazard to staff. ¹
• External contamination. Radioactive material is on the skin, hair, or clothing. It can be detected with a survey meter and removed by decontamination, and it is largely controllable with standard containment. ¹⁷
• Internal contamination. Radioactive material has entered the body by inhalation, ingestion, wound, or absorption. It cannot be wiped off; it delivers a committed dose over time and may warrant decorporation therapy. ²⁸

Confusing these leads to the two classic errors: treating an exposed-only patient as a contamination hazard, or missing internal contamination in a patient whose skin surveys clean.

The contaminated patient rarely endangers the caregiver

The reassuring physics: external dose rates from a contaminated patient are usually low, and the practical controls — time, distance, contamination containment, gloves, gowns, and eye protection — are the same universal precautions staff already use, with the survey meter added. The priority order is fixed: stabilize the patient, then manage contamination. ¹²⁷ This is why the response is anchored in ordinary emergency care with a radiation overlay, not a separate, exotic protocol.

Key Technical Principles

Setting up the radiation emergency area

The RSO's preplan converts a corner of the emergency department into a controlled radiation emergency area (REA) on short notice: a defined route from the ambulance bay, floor covering to control loose contamination, a buffer/control line separating "hot" and "cold" zones, containers for contaminated clothing and waste, and survey instruments staged and checked. Contaminated clothing removal alone typically eliminates the large majority of external contamination. Control-line surveys of staff and equipment leaving the area prevent the contamination from spreading into the wider hospital. ¹⁴

Assessing internal contamination and estimating intake

Once the patient is stable and gross external contamination is removed, the question becomes whether — and how much — radioactive material got inside. The toolkit: ¹²

• Early screening: nasal swabs (nares), wound counts, and surveys of orifices and mouth.
• Bioassay: collection of urine and feces for laboratory analysis.
• Direct counting: for gamma-emitting radionuclides, whole-body or organ counting.

Measured activity is converted to an intake using known biokinetic models, and the intake is compared against a reference such as the annual limit on intake (ALI) or a clinical decision guide to decide whether decorporation is justified. As one review describes, an early estimate can be made at the bedside by measuring activity, converting count rate to disintegration rate with the detector efficiency and the radionuclide's specific gamma-ray constant, and comparing the result to its ALI or derived reference level. ²

A worked estimate: from intake to committed dose

The ALI provides a convenient anchor because it is defined against a dose limit. By construction, one ALI (stochastic) corresponds to a committed effective dose of 50 mSv (5 rem) — the older annual occupational reference. So a first-order estimate of committed effective dose from a measured intake is simply:

Worked example. Suppose bioassay and biokinetic modeling indicate a patient inhaled an intake equal to 0.2 ALI of a radionuclide. Then:

a committed effective dose of about 10 mSv — informative for counseling and for deciding whether decorporation (which lowers the committed dose by increasing excretion) is worthwhile. This is a screening estimate; a definitive dose uses radionuclide-specific dose coefficients and serial bioassay, and the averted dose from therapy can itself be calculated per exposure route. ² For the survey and counting methods behind these measurements, see our guide on minimum detectable activity in contamination surveys.

Decorporation: matching the agent to the radionuclide

Decorporation increases the excretion rate of an internalized radionuclide, reducing the committed dose. The FDA-approved agents each target specific chemistries: ⁶⁸⁹

Two clinical nuances matter. First, timing dominates efficacy — KI and DTPA work best the sooner they are given, so preplanning and rapid access to the agents (or to the national resources that supply them) is part of the RSO's job. Second, Ca-DTPA is generally favored in the first 24 hours after a transuranic intake, with Zn-DTPA preferred for continued treatment and in pregnancy. ⁶⁸

Clinical Impact

Getting this framework right changes outcomes on several fronts:

• The patient is stabilized. Preplanning prevents the paralysis that delays care for a treatable injury. The medical emergency, treated first, is what most often determines survival. ¹⁷
• Committed dose is reduced when it counts. Prompt, correctly matched decorporation measurably lowers the committed effective dose for internalized cesium, transuranics, and radioiodine — but only if the agents are available and given early. ⁶⁸
• The hospital keeps functioning. Disciplined contamination control at the control line keeps the event contained to the REA rather than shutting down the emergency department.
• Staff are protected and reassured. Documented low staff doses, established through personal dosimetry and surveys, turn fear into evidence and let the team focus on care. ¹

The same instrumentation and survey discipline that supports a contamination event underpins routine practice; see our guides on choosing the right radiation survey meter and radioactive material spill response.

Practical Optimization Tips

1. Preplan the radiation emergency area before you need it

Designate the route, the control line, the coverings, the waste containers, and the instrument cache in writing, and rehearse it. The plan should assume little or no advance notice. ¹⁴

2. Post the fixed priority order everywhere

"Medical first, contamination second." Make it a printed line on the REA setup checklist so no one has to remember it under stress. ¹⁷⁸

3. Remove clothing early — it is the fastest decontamination step

Removing and bagging outer clothing eliminates most external contamination in one action, before any washing. Survey again afterward and prioritize wounds and orifices. ¹

4. Collect bioassay samples early and label them

Early urine, feces, and swab samples are the record on which intake — and any decorporation decision — will rest. Do not lose the early window. ²

5. Know your source of countermeasures in advance

Confirm where KI, Prussian blue, and Ca-/Zn-DTPA come from for your facility and how fast, and build that into the plan. Timing is everything for decorporation efficacy. ⁶⁸

6. Survey people and equipment at the control line

Nothing leaves the REA without a survey. This is what keeps a single contaminated patient from becoming a contaminated department. ¹⁴

Common pitfalls to avoid

• Letting the survey meter override triage. The alarming meter does not change the fact that the medical emergency comes first. ²⁷
• Assuming a clean skin survey means no internal contamination. Internal contamination requires its own assessment. ²
• Waiting for a "radiation team" before starting care. Emergency staff, with an RSO overlay, provide the care; the physics supports it.
• Having agents but no speed. Decorporation delayed is decorporation diminished. ⁶
• No control line. Without it, contamination spreads and the event grows.
• Overtreating an exposed-only patient. Irradiation without contamination needs no decontamination. ¹

Regulatory Considerations

A hospital's contaminated-patient response lives at the intersection of its radioactive material license, radiation-protection regulations, and emergency-preparedness standards — and the medical physicist/RSO is expected to have it documented before an event, not improvised during one.

Key frameworks:

• NCRP Report No. 161, Volumes I and II, "Management of Persons Contaminated with Radionuclides." The authoritative U.S. guidance: Volume I is the responder handbook (onsite, prehospital, hospital treatment, and follow-up), and Volume II provides the scientific and technical bases. ¹³
• NCRP Report No. 165, "Responding to a Radiological or Nuclear Terrorism Incident: A Guide for Decision Makers." Frames the larger-scale response and decision points that a hospital plan must fit within. ⁴
• IAEA EPR-Medical 2024, "Generic Procedures for Medical Response During a Nuclear or Radiological Emergency" (the current revision superseding the 2005 edition). Provides adaptable procedures for the medical response. ⁵
• 10 CFR Part 20, "Standards for Protection Against Radiation." Sets the occupational total-effective-dose-equivalent limit of 50 mSv (5 rem) per year (20.1201), the public limit of 1 mSv per year (20.1301), and the preplanned, informed-consent framework of planned special exposures (20.1206) relevant to rare lifesaving actions. ¹⁰
• FDA-approved decorporation agents. Radiogardase (Prussian blue) for cesium/thallium, and Ca-DTPA and Zn-DTPA for plutonium/americium/curium, are FDA-approved, and KI is the approved thyroid-blocking agent. ⁶⁹

Jurisdiction shapes reporting and licensing. Of the states DRPS serves, Florida, Maryland, Virginia, California, Nevada, Pennsylvania, New York, and New Jersey are NRC Agreement States that regulate medical use of radioactive material under their own radiation-control programs, while Washington, DC and Delaware are regulated directly by the NRC. A facility must know which authority governs its license, its dose limits, and its incident-reporting obligations. This preparedness work is coordinated with the facility's radiation safety officer program and reinforced through radiation safety training; for the reporting side, see reporting radiation incidents to the NRC.

Frequently Asked Questions (FAQs)

Is a radioactively contaminated patient dangerous to emergency department staff?

Rarely to a degree that changes care. The radiation dose to staff from a typical contaminated patient is low, and no one has died from internal contamination itself. Life- and limb-threatening medical conditions are stabilized first; contamination control is layered on top with standard PPE, surveys, and containment. Staff protection relies mainly on time, distance, contamination control, and good technique.

What is the difference between contamination, exposure, and internal contamination?

Exposure means the person was in a radiation field but is not itself radioactive, like a chest X-ray, and needs no decontamination. External contamination is radioactive material on the skin or clothing, which can be surveyed and removed. Internal contamination is radioactive material taken into the body by inhalation, ingestion, or through wounds, and it delivers a committed dose that may warrant decorporation therapy.

Do we treat contamination or the medical emergency first?

The medical emergency first. Standard practice is to stabilize airway, breathing, circulation, and life-threatening injuries before addressing contamination, because the acute medical threat is almost always the greater and more immediate risk. Contamination is controlled concurrently and decontamination proceeds once the patient is stable.

What is Prussian blue used for?

Prussian blue (Radiogardase) is an FDA-approved decorporation agent for internal contamination with cesium-137 or radioactive thallium. It binds these ions in the gastrointestinal tract and interrupts their reabsorption, accelerating fecal excretion and reducing the committed dose. It is not effective for plutonium, americium, or curium, which require DTPA.

When is Ca-DTPA versus Zn-DTPA used?

Ca-DTPA and Zn-DTPA are FDA-approved to treat internal contamination with plutonium, americium, or curium by forming stable complexes that are excreted in urine. Ca-DTPA is generally more effective in the first 24 hours after intake, while Zn-DTPA is preferred for prolonged or repeated treatment and in pregnancy. Both work best when given as soon as possible after intake.

How is internal contamination measured?

Internal contamination is estimated from nasal and wound swabs, bioassay of urine and feces, and, for gamma-emitting radionuclides, direct or whole-body counting. Measured activity is converted to an intake using known biokinetics, then compared with the annual limit on intake or a clinical decision guide to decide whether decorporation is warranted and to estimate the committed effective dose.

What dose limits apply to staff caring for a contaminated patient?

Routine occupational limits under 10 CFR Part 20 are 50 mSv (5 rem) per year total effective dose equivalent, with the public limit at 1 mSv (0.1 rem) per year. Care of a contaminated patient normally keeps staff far below these limits. For rare lifesaving situations, emergency-worker dose guidance addresses higher, voluntary, informed-consent turn-back levels, but these are exceptional and preplanned, not routine.

Should our hospital preplan for this even if it seems unlikely?

Yes. Contaminated patients can arrive from industrial or nuclear-medicine mishaps, transportation accidents, or a radiological incident, often with little warning and before any formal notification. A preplanned radiation emergency area, trained staff, stocked survey instruments and countermeasures, and a clear RSO call tree turn a chaotic event into a managed one.

Key Takeaways

• Patient first, contamination second. The medical emergency almost always outweighs the radiological one, and no one dies from internal contamination itself. ¹²⁷
• Exposure, external contamination, and internal contamination are three different problems with three different responses. ¹²
• The contaminated patient rarely endangers staff. Standard PPE, a control line, time, and distance keep caregiver dose low. ¹
• Estimate intake early. Swabs, bioassay, and counting feed an intake estimate that, against the ALI, yields a committed-dose screen: E₅₀ ≈ (Intake/ALI) × 50 mSv. ²¹⁰
• Match the decorporation agent to the radionuclide, fast. KI for radioiodine, Prussian blue for cesium/thallium, Ca-/Zn-DTPA for transuranics — all more effective the earlier they are given. ⁶⁸⁹
• Preplan against NCRP and IAEA guidance. An REA, trained staff, staged instruments, and a call tree turn chaos into a managed event. ¹⁴⁵

Conclusion

The radioactively contaminated patient is one of the few scenarios where the right instinct is the opposite of the reflexive one. The survey meter says "danger, keep away"; the correct response is to step in, stabilize the patient, and manage the contamination with the same disciplined universal precautions used every day, plus a control line and a survey. The radiation is real, but it is slow, measurable, and — for internalized material — often treatable with agents matched to the radionuclide and given early.

That calm competence does not appear on the day of an event. It is built beforehand by the RSO and medical physicist: a written radiation emergency area plan, trained and drilled staff, staged and calibrated instruments, a known supply line for countermeasures, and dosimetry that later proves staff were protected. Hospitals that treat this as a preparedness project — not a hypothetical — protect the patient, their staff, and their ability to keep the doors open.

How DRPS Can Help

Diagnostic Radiation Physics Services helps hospitals and imaging facilities build and audit contaminated-patient preparedness: radiation emergency area planning, contamination-control and control-line procedures, survey-instrument selection and calibration programs, internal-dose assessment methodology, decorporation-access planning, and the staff training and drills that make the plan real. This is delivered through radiation safety officer support, radiation safety training, and medical physics consulting.

DRPS supports facilities across our service locations, including Florida, Maryland, Virginia, Washington DC, California, Nevada, New York, Pennsylvania, New Jersey, and Delaware.

The goal is simple: when a contaminated patient comes through the door, the team already knows exactly what to do — and does it calmly.

Related Resources

• Radioactive material spill response
• Minimum detectable activity in contamination surveys
• Skin dose from radioactive contamination
• Thyroid bioassay for I-131 workers
• NRC occupational dose limits (Part 20)
• Nuclear medicine decontamination best practices
• Radiation Safety Officer consulting
• Radiation safety training

References

1. National Council on Radiation Protection and Measurements. NCRP Report No. 161, Vol. I: Management of Persons Contaminated with Radionuclides — Handbook. Bethesda, MD: NCRP; 2008. ncrponline.org
2. Dainiak N, Albanese J. Assessment and clinical management of internal contamination. J Radiol Prot. 2022;42(4):041501. doi:10.1088/1361-6498/aca0a7. PubMed
3. National Council on Radiation Protection and Measurements. NCRP Report No. 161, Vol. II: Management of Persons Contaminated with Radionuclides — Scientific and Technical Bases. Bethesda, MD: NCRP; 2008. ncrponline.org
4. National Council on Radiation Protection and Measurements. NCRP Report No. 165: Responding to a Radiological or Nuclear Terrorism Incident — A Guide for Decision Makers. Bethesda, MD: NCRP; 2010. ncrponline.org
5. International Atomic Energy Agency. Generic Procedures for Medical Response During a Nuclear or Radiological Emergency (EPR-Medical 2024). Vienna: IAEA; 2024. iaea.org
6. Kazzi Z, Buzzell J, Bertelli L, Christensen D. Emergency department management of patients internally contaminated with radioactive material. Emerg Med Clin North Am. 2015;33(1):179-196. doi:10.1016/j.emc.2014.09.008. PubMed
7. Yamamoto LG. Risks and management of radiation exposure. Pediatr Emerg Care. 2013;29(9):1016-1026. doi:10.1097/PEC.0b013e3182a380b8. PubMed
8. U.S. Food and Drug Administration. Guidance for Industry: Internal Radioactive Contamination — Development of Decorporation Agents. Silver Spring, MD: FDA. fda.gov
9. U.S. Food and Drug Administration. Radiation Emergencies — FDA-approved products for radiation exposure and contamination (Radiogardase, Ca-DTPA, Zn-DTPA, potassium iodide). fda.gov
10. U.S. Nuclear Regulatory Commission. 10 CFR Part 20: Standards for Protection Against Radiation. ecfr.gov